Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Albuterol Spiromax and ProAir HFA in Pediatric Asthma
NCT01899144Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jul 2013
- Primary completion
- Oct 2013
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of albuterol spiromax in asthma, sponsored by Teva Pharmaceutical Industries Ltd.. Started Jul 2013; status: completed.
02
Drugs
albuterol spiromax
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01899144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01899144.